Pivotal role of inflammation in vascular endothelial dysfunction of hyperlipidemic rabbit and effects by atorvastatin

International Journal of Cardiology

Volumn 146, Issue 2, 2011, Pages 140-144

  Chen, Yang Xin ^a   Wang, Xiao Qiao ^b   Fu, Yun ^a   Yao, You Jie ^a   Kong, Min Yi ^a   Nie, Ru Qiong ^a   Wang, Jing Feng ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Atorvastatin; Endothelial function; High fat diet; Inflammatory markers

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; ENDOTHELIN 1; GLUCOSE; INSULIN; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC OXIDE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOVASCULAR FUNCTION; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG ACTIVITY; ENDOTHELIAL DYSFUNCTION; GLUCOSE BLOOD LEVEL; HEART MUSCLE RELAXATION; HYPERLIPIDEMIA; INFLAMMATION; LIPID BLOOD LEVEL; LIPID DIET; MALE; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ANIMALS; ANTICHOLESTEREMIC AGENTS; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIETARY FATS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HEPTANOIC ACIDS; HYPERLIPIDEMIAS; INSULIN; LIPIDS; MALE; PYRROLES; RABBITS; VASCULITIS;

EID: 78651461470     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.06.019     Document Type: Article

References (32)

1. R. Ross Atherosclerosis-an inflammatory disease N Engl J Med 340 1999 115 126
2. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874
3. Z.Q. Yan, and G.K. Hansson Innate immunity, macrophage activation, and atherosclerosis Immunol Rev 219 2007 187 203
4. Y. Chen, J. Wang, R. Nie, and S. Zhou Endogenous pro-resolving and anti-inflammatory lipid mediators: the new hope of atherosclerotic diseases Med Hypotheses 71 2008 237 240
5. A.M. Gori, F. Cesari, and R. Marcucci The balance between pro- and anti-inflammatory cytokines is associated with platelet aggregability in acute coronary syndrome patients Atherosclerosis 202 2009 255 262
6. A.J. Merched, K. Ko, K.H. Gotlinger, C.N. Serhan, and L. Chan Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators FASEB J 22 2008 3595 3606
7. B. Weinhold, A. Bader, V. Poli, and U. Rüther Interleukin-6 is necessary, but not sufficient, for induction of the humanC-reactive protein gene in vivo Biochem J 325 1997 617 621
8. A.J. Szalai, F.W. van Ginkel, Y. Wang, J.R. McGhee, and J.E. Volanakis Complement-dependent acute-phase expression of C-reactive protein and serum amyloid P-component J Immunol 165 2000 1030 1035
9. E.T.H. Yeh, and J.T. Willerson Coming of age of C-reactive protein: using inflammation markers in cardiology Circulation 107 2003 370 371
10. G. Niccoli, L.M. Biasucci, and C. Biscione Independent prognostic value of C-reactive protein and coronary artery disease extent in patients affected by unstable angina Atherosclerosis 196 2008 779 785
11. J. Danesh, S. Kaptoge, and A.G. Mann Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review PLoS Med 5 2008 e78
12. P. Järemo, and O. Nilsson Interleukin-6 and neutrophils are associated with long-term survival after acute myocardial infarction Eur J Intern Med 19 5 2008 330 333
13. J.K. Damås, L. Puccetti, and P. Aukrust Early anti-thrombotic and anti-inflammatory actions of statins and fibrates-time for adjuvant therapy in acute coronary syndromes? Thromb Haemost 94 2005 1 3
14. C.P. Sparrow, C.A. Burton, and M. Hernandez Simvastatin has anti-inflammatory and anti-atherosclerotic activities independent of plasma cholesterol lowering Arterioscler Thromb Vasc Biol 21 2001 115 121
15. T.N. Patel, M.H. Shishehbor, and D.L. Bhatt A review of high-dose statin therapy: targeting cholesterol and inflammation in atherosclerosis Eur Heart J 28 2007 664 672
16. M. Hanefeld, N. Marx, and A. Pfützner Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study J Am Coll Cardiol 49 2007 290 297
17. C. Vecchione, and R.P. Brandes Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors oxidative stress and induces endothelial dysfunction in mice Circ Res 91 2002 173 179
18. L. Puccetti, A.L. Pasqui, and M. Pastorelli Platelet hyperactivity after statin treatment discontinuation Thromb Haemost 90 2003 476 482
19. W.T. Lai, K.T. Lee, and C.S. Chu Influence of withdrawal of statin treatment on proinflammatory response and fibrinolytic activity in humans: an effect independent on cholesterol elevation Int J Cardiol 98 2005 459 464
20. M. Leosdottir, P.M. Nilsson, J.A. Nilsson, and G. Berglund Cardiovascular event risk in relation to dietary fat intake in middle-aged individuals: data from The Malmö Diet and Cancer Study Eur J Cardiovasc Prev Rehabil 14 2007 701 706
21. M.J. Raher, H.B. Thibault, and E.S. Buys A short duration of high-fat diet induces insulin resistance and predisposes to adverse left ventricular remodeling after pressure overload Am J Physiol Heart Circ Physiol 295 2008 H2495 2502
22. J.J. Wright, J. Kim, and J. Buchanan Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding Cardiovasc Res 82 2009 351 360
23. S.J. Hernandez-Vallejo, M. Alqub, and S. Luquet Short-term adaptation of postprandial lipoprotein secretion and intestinal gene expression to a high fat diet Am J Physiol Gastrointest Liver Physiol 296 2009 G782 G792
24. S. Devaraj, E. Chan, and I. Jialal Direct demonstration of an antiinflammatory effect of simvastatin in subjects with the metabolic syndrome J Clin Endocrinol Metab 91 2006 4489 4496
25. A. Mauriello, G. Sangiorgi, and S. Fratoni Diffuse and active inflammation occurs in both vulnerable and stable plaques of the entire coronary tree: a histopathologic study of patients dying of acute myocardial infarction J Am Coll Cardiol 45 2005 1585 1593
26. A. Kerner, L. Gruberg, and A. Goldberg Relation of C-reactive protein to coronary collaterals in patients with stable angina pectoris and coronary artery disease Am J Cardiol 99 2007 509 512
27. H. Duygu, M. Zoghi, and S. Nalbantgil High-sensitivity C-reactive protein may be an indicator of the development of atherosclerosis in myocardial bridging Int J Cardiol 124 2008 267 270
28. P.M. Ridker, N. Rifai, and M.A. Pfeffer Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators Circulation 98 1998 839 844
29. C. Heeschen, C.W. Hamm, U. Laufs, S. Snapinn, M. Böhm, and H.D. White Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators. Withdrawal of statins increases event rates in patients with acute coronary syndromes Circulation 105 2002 1446 1452
30. F.A. Spencer, G.C. Fonarow, and P.D. Frederick National Registry of Myocardial Infarction. Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: National Registry Of Myocardial Infarction Arch Intern Med 164 2004 2162 2168
31. O. Schouten, S.E. Hoeks, and G.M. Welten Effect of statin withdrawal on frequency of cardiac events after vascular surgery Am J Cardiol 100 2007 316 320
32. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150